A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1994
11/17/1994	EP0300033B1 Cytotoxic lymphocyte-specific protease-related molecules and methods
11/16/1994	CN1026588C Novel 1-alkyl substituted benzimidazole derivatives
11/15/1994	US5364859 Antiinflammatory agents, antiallergens, bronchodilators
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/13/1994	CA2123261A1 Urethanes and ureas that induce cytokine production
11/11/1994	CA2121567A1 Substituted pyrroles
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
11/10/1994	WO1994025453A1 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025043A1 Peptides and compounds that bind to elam-1
11/10/1994	WO1994025022A1 Rapamycin conjugates and antibodies
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994021675A3 T cell epitopes of ryegrass pollen allergen
11/10/1994	WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2161101A1 Rapamycin conjugates and antibodies
11/10/1994	CA2160909A1 Cell-targeted lytic pore-forming agents
11/09/1994	EP0623674A1 Interleukin-1 receptors
11/09/1994	EP0623614A1 4-Aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
11/09/1994	EP0623606A2 Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
11/09/1994	EP0623603A1 Styrene derivative and salts thereof
11/09/1994	EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors
11/09/1994	EP0623348A1 The use of AICA riboside and ribavirin for the preparation of a medicament for the treatment of allergies
11/09/1994	EP0623168A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
11/09/1994	EP0623133A1 Substituted amino alkyl compounds
11/09/1994	EP0623126A1 Imidazole derivatives and their use as cytokine inhibitors
11/09/1994	EP0623116A1 Amino acid derivatives as paf-receptor antagonists
11/09/1994	EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/09/1994	EP0570401B1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
11/09/1994	CN1094710A Compounds
11/09/1994	CN1094640A Urease-based vaccine against helicobacter infection
11/09/1994	CN1094614A Antiallergic composition for ophthalmic or nasal use
11/08/1994	US5362735 Fungicides, immunosuppresants, antitumor agents
11/08/1994	US5362733 Lipid peroxidation prevention
11/08/1994	US5362732 Boronated compounds
11/08/1994	US5362721 Corticoid-17-alkyl-carbonates substituted in the 17-position, process for their preparation and pharmaceuticals containing them
11/08/1994	US5362718 Antibody inhibitors, antiinflammatory agents, fungicides, antitumor agents
11/08/1994	US5362716 Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
11/08/1994	US5362492 Method of inhibiting multiple organ failure in trauma patients by administration of superoxide dismutase
11/08/1994	CA2123057A1 Quinoline derivatives with pharmacological activity
11/08/1994	CA2123055A1 Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors
11/08/1994	CA2011428C Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
11/08/1994	CA1332944C Isoquinoline derivatives, their preparation and their use
11/02/1994	EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use
11/02/1994	EP0622361A1 Heterocyclic compounds as bradykinin antagonists
11/02/1994	EP0621898A1 Chimeric immunogens
11/02/1994	EP0621865A1 Rapamycin derivative and its medicinal use
11/02/1994	EP0621789A1 Pharmaceutical pentapeptide compositions and methods of use thereof
11/02/1994	EP0621786A1 Induced tolerance to xenografts
11/02/1994	EP0621780A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
11/02/1994	EP0621778A1 $i(M. FERMENTANS) INFECTION TREATMENT
11/02/1994	EP0426667B1 Composition for macrophage activation
11/02/1994	EP0396560B1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans
11/01/1994	US5360792 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
11/01/1994	US5360117 Process for the extraction of peat and apparatus for carrying out the process
11/01/1994	CA1332838C 4-alkyl-1,4-dihydropyridines with paf-acether-antagonist activity
11/01/1994	CA1332835C Aliphatic carboxamides
11/01/1994	CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/30/1994	CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors
10/27/1994	WO1994024167A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
10/27/1994	WO1994024152A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
10/27/1994	WO1994024145A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	WO1994023734A1 Method of treatment of diseases by deletion of t cells
10/27/1994	WO1994023733A1 New cyclosporine-containing pharmaceutical compositions for oral administration
10/27/1994	WO1994023728A1 Immunogenic cancer proteins and peptides and method of use
10/27/1994	WO1994023718A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
10/27/1994	WO1994016068A3 Allergenic proteins and peptides from dog dander and uses therefor
10/27/1994	CA2161143A1 New pharmaceutical preparations comprising cyclosporin for oral administration
10/27/1994	CA2160713A1 Immunogenic cancer proteins and peptides and method of use
10/27/1994	CA2160370A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	CA2159891A1 Method of treatment of diseases by deletion of t cells
10/27/1994	CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations
10/27/1994	CA2137148A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
10/26/1994	EP0621341A2 Monoclonal antibodies to bovine cytokines
10/26/1994	EP0621038A1 Pharmaceutical compositions containing silicate polymers
10/26/1994	EP0620824A1 Peptides with tachykinin antagonist activity
10/26/1994	EP0620735A1 Use of ruthenium red for inhibiting immune response
10/26/1994	EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides
10/26/1994	CN1094052A Heterocycle-containing carbonic acid derivatives
10/26/1994	CN1094050A Novel heterocyclic compounds with antiasthmatic/anti-auergie, anti-inflammatory positive inotropic and blood pressure-reducing effect
10/26/1994	CN1094048A Pyrazolopyrimidines
10/26/1994	CN1094046A Novel compounds
10/26/1994	CN1094038A Amino-substituted pyrazoles
10/26/1994	CN1094034A 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment
10/26/1994	CN1094028A Catechol diethers as selective PDE(IV) inhibitors
10/26/1994	CN1093904A Compositions for the regulation of cytokine activity
10/25/1994	US5359083 Process for the preparation of substituted indoles
10/25/1994	US5359076 Cyclic aminophenylacetic acid derivatives, process for preparing the same and immune response modulator having the same as an effective ingredient
10/25/1994	US5359063 Heterocyclene derivatives
10/25/1994	US5358955 Antiinflammatory agents
10/25/1994	US5358953 Imidazopyridine PAF/H1 antagonists
10/25/1994	CA1332712C Intravenous pharmaceutical composition
10/23/1994	CA2121096A1 Monoclonal antibodies to bovine cytokines
10/21/1994	CA2121613A1 Active compound from a sponge
10/19/1994	EP0620276A1 Humanised antibodies
10/19/1994	EP0620214A1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
10/19/1994	EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins

1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 1172